Clik here to view.
Clik here to view.
CAI任命Sheena Dempsey为首席执行官
印第安纳波利斯 (美国商业资讯)– 全球专业服务公司、运营准备和卓越运营的先驱CAI今天宣布任命Sheena Dempsey为首席执行官。Dempsey在全球业务转型、销售与运营、损益管理以及创建和培养高绩效团队方面拥有超过25年的专业经验，是一位广受尊敬、成就卓著的高管。在新岗位上，她将领导CAI成为全球合作伙伴，持续致力于通过创新方法和技术确保客户做好运营准备。...
View ArticleClik here to view.
Global Healthy Living Foundation Partners with The Bone Bus to Enhance Rural...
UPPER NYACK, N.Y. & SYDNEY The Global Healthy Living Foundation Australia (GHLF Australia) is proud to announce its collaboration with The Bone Bus, an Australian traveling bone density...
View ArticleClik here to view.
Kewpie Confirms Improved Ease of Eating Vegetables and Other Foods Through...
TOKYO Kewpie Corporation (“Kewpie”) (TOKYO:2809) has confirmed that adding mayonnaise or emulsified dressings improves the ease of eating of foods such as vegetables that the elderly find difficult...
View ArticleClik here to view.
Children’s Hospital Los Angeles 连续 16 年被评为美国 10 大儿童医院之一。
洛杉矶 (美国商业资讯)– 作为儿科学术医学的领导者，Children’s Hospital Los Angeles（洛杉矶儿童医院，CHLA）通过发现和进步来增强健康和拯救生命，继续履行其使命。目前，Children’s Hospital Los Angeles 被公认为美国十大儿科医院之一。根据《美国新闻与世界报道》发布的 2024-25 年度 最佳儿童医院排名，Children’s...
View ArticleClik here to view.
Kewpie证实，通过添加蛋黄酱或乳化型沙拉汁，蔬菜和其他食物会变得更易于进食
东京 (美国商业资讯)– Kewpie Corporation (“Kewpie”) (TOKYO:2809)已证实，添加蛋黄酱或乳化型沙拉汁可使老年人难以食用的食物（如蔬菜）变得更易于进食。这是通过与和洋女子大学的Yukie Yanagisawa教授等人开展的联合研究得出的结论。这项研究的结果是在2024年9月14日至15日举行的日本咀嚼科学与健康促进学会第35届大会上公布的。...
View ArticleClik here to view.
报告强调了创新对实现“欧盟无烟”的重要作用
葡萄牙里斯本 (美国商业资讯)– We Are Innovation (WAI) 发布了题为《欧盟的无烟未来与创新的作用——欧洲晴雨表539特别调查结果》的简报。 该文件指出，除非修订欧盟的禁烟策略，否则欧盟离实现无烟环境还有很长的路要走。...
View ArticleClik here to view.
スモークフリーの欧州を目指し、イノベーションの重要性を強調するレポートを発表
ポルトガル、プラハ （ビジネスワイヤ） — We Are Innovation（WAI）は、報告書「EUにおけるスモークフリーの未来とイノベーションの役割 — 特別ユーロバロメーター539の調査結果」を発表しました。 この報告書は、EUが喫煙対策の戦略を改訂しない場合に、スモークフリー実現の道のりがいかに遠いかを検証しています。...
View ArticleClik here to view.
Dr. Reddy’s Launches Comprehensive Menopause Support Program and Training for...
PRINCETON, N.J. Dr. Reddy’s Laboratories Inc., the U.S. arm of Dr. Reddy’s Laboratories Ltd., a global pharmaceutical company headquartered in Hyderabad, India, today announced the launch of a...
View ArticleClik here to view.
Celltrion presents 2-year post-hoc analysis findings for subcutaneous...
INCHEON, South Korea Celltrion today announced two-year results of subcutaneous infliximab (CT-P13 SC) dose escalation therapy at United European Gastroenterology (UEG) Week 2024 in Vienna. The...
View ArticleClik here to view.
NAMSA and TERUMO Announce Strategic Outsourcing Partnership
TOLEDO, Ohio & TOKYO NAMSA, a world-leading MedTech Contract Research Organization (CRO) offering end-to-end market access services, and TERUMO, a global leader in medical technology, announced...
View ArticleClik here to view.
First Photorealistic AI Avatar for People Living with Alzheimer’s and...
SEATTLE Today at Lenovo Tech World, Lenovo™ in collaboration with Innovations in Dementia, launched Alzheimer’s Intelligence, a photorealistic 3D avatar with custom AI based on the lived experiences...
View ArticleClik here to view.
セルトリオン、インフリキシマブ皮下注製剤（CT-P13...
韓国仁川（インチョン） （ビジネスワイヤ） — セルトリオンは、ウィーンで開催された2024年 欧州消化器病（UEG）週間において、インフリキシマブ皮下注製剤（CT-P13...
View ArticleClik here to view.
Lenovo与Innovations in Dementia合作推出首个针对阿尔茨海默氏症和痴呆症患者的逼真人工智能化身
西雅图 (美国商业资讯)– 今天在Lenovo Tech World大会上，Lenovo™与Innovations in Dementia合作推出Alzheimer’s...
View ArticleClik here to view.
Sunbird Bio Raises Additional $14 Million to Advance Broadest Blood-Based...
CAMBRIDGE, Mass. and SINGAPORE Sunbird Bio, a biotechnology company developing proprietary blood-based technologies to improve diagnosis and treatment of neurological disorders and early-stage...
View ArticleClik here to view.
レノボとInnovations in Dementiaが、アルツハイマー病・認知症患者向けの初となるフォトリアリスティックAIアバターを発表
シアトル （ビジネスワイヤ） — Lenovo™はLenovo Tech Worldにて、Innovations in...
View ArticleClik here to view.
Celltrion公布皮下注射英夫利西单抗（CT-P13 SC）的两年事后分析结果，强调剂量递增是控制炎症性肠病继发性失应答的可选方案
韩国仁川 (美国商业资讯)– Celltrion今天在维也纳举行的“2024年欧洲联合胃肠病学（UEG）周”（United European Gastroenterology (UEG) Week 2024）上宣布了皮下注射英夫利西单抗（CT-P13 SC）剂量递增疗法的两年结果。...
View ArticleClik here to view.
CopilotIQ and Biofourmis Merge to Create the First End-to-End Platform for...
NASHVILLE, Tenn. & BOSTON CopilotIQ, the health tech company helping older Americans with chronic conditions live longer and healthier lives, and Biofourmis, a global technology-enabled care...
View ArticleClik here to view.
Catawba Research Announces Strategic Partnership With PharmaLegacy Laboratories
CHARLOTTE, N.C. Catawba Research, a leading global full-service Clinical Research Organization (CRO), is proud to announce a strategic partnership with PharmaLegacy Laboratories, a recognized leader...
View ArticleClik here to view.
Otsuka Announces Positive Interim Results from the Phase 3 Trial of...
PRINCETON, N.J. & TOKYO Otsuka Pharmaceutical Development & Commercialization, Inc. and Otsuka Pharmaceutical, Co. Ltd. (Otsuka), today announce positive topline interim data from the...
View Article